PTC Therapeutics
PTCT
$36.36
Share price
1.54%
Change (1 day)
-16.41%
Change (1 year)
Categories
Market capitalization of PTC Therapeutics (PTCT)
Market cap: $2.78 Billion
As of June 2024 PTC Therapeutics has a market cap of $2.78 Billion. This makes PTC Therapeutics the world's 3595th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of PTC Therapeutics from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.78 B | 34.09% |
| 2023 | $2.07 B | -25.34% |
| 2022 | $2.78 B | -1.08% |
| 2021 | $2.81 B | -32.38% |
| 2020 | $4.16 B | 39.99% |
| 2019 | $2.97 B | 71.28% |
| 2018 | $1.73 B | 150.97% |
| 2017 | $0.69 B | 84.84% |
| 2016 | $0.37 B | -65.93% |
| 2015 | $1.09 B | -35.48% |
| 2014 | $1.70 B | 321.63% |
| 2013 | $0.40 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of PTC Therapeutics was reported to be:
$2.78 Billion
$2.78 Billion
$2.78 Billion
$2.78 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $210.42 B | 7,445.73% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | $117.50 B | 4,113.51% | 🇺🇸 USA |
 Xencor XNCR | $1.46 B | -47.46% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $12.27 B | 340.16% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.41 B | -84.98% | 🇺🇸 USA |
 Avidity Biosciences RNA | $2.56 B | -7.89% | 🇺🇸 USA |